[Prenatal diagnosis of congenital diseases by means of the biochemical study of the amniotic fluid obtained in the 16th week of pregnancy].
D000328:Adult; D000596:Amino Acids / Q000032:analysis; D000649:Amniocentesis; D000653:Amniotic Fluid / Q000032:analysis* / Q000166:cytology; D002241:Carbohydrates / Q000032:analysis; D000013:Congenital Abnormalities / Q000175:diagnosis*; D004798:Enzymes / Q000032:analysis; D005260:Female; D005315:Fetal Diseases / Q000175:diagnosis*; D030342:Genetic Diseases, Inborn / Q000175:diagnosis*; D006025:Glycosaminoglycans / Q000032:analysis; D006801:Humans; D007621:Karyotyping; D008661:Metabolism, Inborn Errors / Q000175:diagnosis*; D011247:Pregnancy; D011262:Pregnancy Trimester, Second; D011506:Proteins / Q000032:analysis; D000509:alpha-Fetoproteins / Q000032:analysis
D000596:Amino Acids; D002241:Carbohydrates; D004798:Enzymes; D006025:Glycosaminoglycans; D011506:Proteins; D000509:alpha-Fetoproteins
La diagnosi prenatale di malattie congenite mediante studio biochimico del liquido amniotico prelevato in 16a settimana di gravidanza